| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004546 | American Journal of Ophthalmology | 2008 | 7 Pages |
Abstract
Patients with Behçet disease had significant decrease in inflammation, improvement of visual acuity, and reduced ocular complications following infliximab when compared to conventional therapy. The number of relapses was less in the infliximab treatment group than the conventional therapy group.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Khalid F. Tabbara, Amal I. Al-Hemidan,